Pharma News

The latest developments from pharmaceutical and biopharmaceutical companies, both innovator and generic-drug companies, and leading regulatory news.

UCB has agreed to acquire Ra Pharmaceuticals, a clinical-stage biopharmaceutical company focused on therapies for rare diseases, for a total transaction value of approximately $2.1 billion. Under the agreement, Ra Pharma shareholders will receive...

GlaxoSmithKline (GSK) has formed a five-year collaboration with Lyell Immunopharma, a San Francisco-based adoptive cell therapy biotechnology company, to develop new technologies for cell therapies for treating solid tumors. The collaboration will...

A jury has issued a verdict to award punitive damages of $8 billion against Johnson & Johnson (J&J) relating to litigation involving Risperdal (risperidone), an antipsychotic drug used to treat certain mental/mood disorders, such as...

A roundup of developments and latest news from China (Biocad, Shanghai Pharma), India (Aurobindo, Glenmark, Lupin), and the US (Astellas). China Russia’s Biocad, Shanghai Pharma Finalize Joint Venture Biocad, a Russian pharmaceutical company,...

Janssen Sciences Ireland, part of Johnson & Johnson, has opened a new 19,100-square-meter building for biomanufacturing in Ringaskiddy, County Cork, Ireland. The company has operated a biopharmaceutical supply chain facility on its 40-hectare...

Johnson & Johnson (J&J) and its Janssen Pharmaceutical Companies have reached a settlement agreement on pending opioid litigation with the Ohio counties of Cuyahoga and Summit that resolves all of the counties’ claims and removes the...

Swedish Orphan Biovitrum (Sobi), a Stockholm, Sweden-based pharmaceutical company specializing in treatments for rare diseases, has agreed to acquire Dova Pharmaceuticals, a Durham, North Carolina-based clinical-stage biopharmaceutical company, by...